Sphera Funds Management’s Neos Therapeutics, Inc NEOS Stock Holding History

Sphera Funds Management’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-950,311	Closed	-$651K	–	125
2020 Q2	$651K	Sell	950,311 -1,559,157	-62%	-$1.24M	0.06%	82
2020 Q1	$1.88M	Sell	2,509,468 -1,021,263	-29%	-$1.4M	0.24%	56
2019 Q4	$5.33M	Sell	3,530,731 -377,534	-10%	-$566K	0.44%	53
2019 Q3	$5.78M	Buy	3,908,265 +196,811	+5%	+$319K	0.89%	34
2019 Q2	$4.79M	Buy	3,711,454 +1,509,757	+69%	+$2.78M	0.66%	44
2019 Q1	$5.75M	Hold	2,201,697	–	–	0.52%	45
2018 Q4	$3.63M	Buy	2,201,697 +1,370,000	+165%	+$3.84M	0.41%	55
2018 Q3	$4.03M	Buy	831,697 +479,555	+136%	+$2.72M	0.46%	63
2018 Q2	$2.2M	Buy	352,142 +31,450	+10%	+$234K	0.3%	82
2018 Q1	$2.66M	Buy	320,692 +150,660	+89%	+$1.44M	0.4%	68
2017 Q4	$1.73M	Buy	+170,032	New	+$1.63M	0.2%	102

Other funds holding NEOS

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sphera Funds Management's NEOS Position: Q3 2020 in Review

Sphera Funds Management sold out of Neos Therapeutics, Inc (NEOS) in Q3 2020, closing a stake of 950,311 shares — an estimated $651K sold.

Sphera Funds Management first reported a position in NEOS in Q4 2017 and held it in 11 quarters. The position peaked at $5.78M in Q3 2019. 41 funds tracked by Wall St. Rank hold NEOS as of Q3 2020.

Sphera Funds Management reported no remaining Neos Therapeutics, Inc position as of Q3 2020 after selling out during the quarter.
Sphera Funds Management sold 950,311 Neos Therapeutics, Inc shares in Q3 2020, an estimated $651K.
Sphera Funds Management first reported a position in Neos Therapeutics, Inc in Q4 2017 and held it in 11 quarters.
Sphera Funds Management's Neos Therapeutics, Inc position peaked at $5.78M in Q3 2019.
41 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q3 2020.

Based on Sphera Funds Management's 13F filing for Q3 2020, filed 12 Nov 2020.